临床路径管理对糖尿病患者住院天数和住院费用的影响被引量：4

Impact of Clinical Pathways Management on Hospitalization Days and Expenses

导出

摘要目的：探讨临床路径管理对糖尿病患者住院天数和住院费用的影响,为临床治疗提供依据。方法：选择2012年1月～2014年12月本院收治的2型糖尿病住院患者245例,按照随机数字表法分为观察组和对照组,观察组实施临床路径管理,对照组按照一般治疗方法管理。比较两组患者住院天数、住院费用,血糖监测技术、胰岛素注射技术掌握情况以及患者满意度。结果：观察组患者住院天数和住院费用均少于对照组,差异有统计学意义（t=-15.700、-19.688;P〈0.05）。观察组患者血糖监测技术和胰岛素注射技术掌握率均为100%,显著高于对照组93.91%和86.96%,差异有统计学意义（Z=-13.450,-12.152;P〈0.05）。观察组患者总满意度为100%,高于对照组总满意度98.26%,差异有统计学意义（Z=-14.098;P〈0.05）。结论：对糖尿病患者实施临床路径管理,能够减少患者住院天数、降低住院费用、提高患者自我管理能力、提高患者满意度,值得临床推广借鉴。 Objective： To explore the impact of clinical pathways management on the hospitalization days and expenses, and provide evidence for clinical therapy. Methods： A toal of 245 patients with type 2 diabetes, who wee treated in Handan Sixth Hospital from January 2012 to December 2014, were selected and randomly divided into observation group and control group. The observation group was managed by clinical pathways, while the control group, by general treatment method. The hospitalization days, hospitalization expenses, master rate of blood glucose monitoring and insulin injection and the satisfaction were compared between the two groups. Results：The hospitalization days and hospitalization expenses of observation group were less than those of control group, and the differences were statistically significant（t=-15.700,-19.688; P〈0.05）. The master rates of blood glucose monitoring and insulin injection in the observation group were both 100%, which were higher than that（93.91%） and that（86.96%） in the control group, the differences were statistically significant（Z=-13.450,-12.152; P〈0.05）. Total satisfied rate in the observation group was 100%, which was higher than that（98.26%） in the control group, the difference was statistically significant（Z=-14.098; P〈0.05）. Conclusions： Implementing clinical pathway management can reduce the hospitalization days, cut down the hospitalization expenses, improve self-management ability and the satisfaction in patients with diabetes, which is worthy of reference for clinical promotion.

作者张勤俭刘丽红咸洪伟段丽芳姜树勤吴彩花赵斗贵杨新利

机构地区邯郸市第六医院内科邯郸市第一医院皮肤科

出处《现代生物医学进展》 CAS 2016年第9期1724-1726,共3页 Progress in Modern Biomedicine

关键词糖尿病临床路径住院天数住院费用 Diabetes Clinical pathway Hospitalization days Hospitalization expenses

分类号 R587.1 [医药卫生—内分泌]

引文网络
相关文献

参考文献20

1Qiu M, Shen W, Song X, et al. Effects ofprediabetes mellitus alone or plus hypertension on subsequent occurrence of cardiovascular disease and diabetes mellims: longitudinal study [J]. Hypertension, 2015, 65 (3): 525-530.
2关曼璐,虎翼,李林贵,慕兴鹏,李正直.某县医院基于临床路径的两个单病种住院费用控制分析[J].宁夏医科大学学报,2014,36(1):59-61. 被引量：8
3Zhang C, Chow FC, Hart Y, et al. Multieenter cohort study of diabetes mallitus and impaired fasting glucose in HIV.infected patients in Chi- na[J]. J Acquir Immune Doric Syndr, 2015, 68(3): 298-303.
4Kobayashi K, Nakashima N, Inoguchi T, etal. Disease managcraent for diabetes mellitus to prevent the onset and progression of compli- cations[J]. Rinsho Byori, 2012, 60(11): 1101-1106.
5Porteons GH, Neal JM, Slee A, etal. A standardized anesthetic and surgical clinical pathway for esophageal resection:impact on length of stay and major outcomes [J]. Reg Anesth Pain Med, 2015, 40(2): 139-149.
6Khoo KH, Verma CS, Lane DP. Drugging the p53 pathway: under- standing the route to clinical efficacy[J]. Nat Rev Drug Discov, 2014, 13(3): 217-236.
7Waanders F, Visser FW, Gans RO. Current concepts in the manage- ment of diabetic nephropathy[J]. Neth J Meal, 2013, 71(9): 448-458.
8Taneera J, Storm P, Groop L. Downregulation of type II diabetes mel- litus and maturity onset diabetes of young pathways In human pancre- atic islets fi'om hyperglycemic donors[J]. J Diabetes Res, 2014, 2014: 237535.
9Lima MH, Caricllli AM, De Abreu LL, et al. Topical insulin acceler- ates wound healing in diabetes by enhancing the AKT and ERK path- ways: a donhle-blind placebo-controlled clinical trial [J]. PLoS One, 2012, 7(5): e36974.
10Seroussi B, Falcoff H, Ertel-Pau V, et al. Online dissemination of clinical practice guidelines as narrative texts and structured pathways: a case study with the treatment of type 2 diabetes [J]. Stud Health Technol Inform, 2014, 205:28-32.